ctrl K

Xilio Therapeutics Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

0.77

0.02 (1.99%)

At close: May 02, 2025, 3:01 PM

Xilio Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	55.29M	44.7M	120.39M	198.05M	19.24M	48.84M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	1.56M	1.55M	1.55M	194K
Other Long-Term Assets	1.78M	1.6M	267K	1.95M	500K	1.55M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.94M	3.42M	4.11M	4.46M	n/a	1.01M
Total Current Assets	60.23M	48.13M	124.5M	202.52M	20.59M	51.1M
Property-Plant & Equipment	9.06M	11.2M	12.84M	13.6M	13.68M	9.87M
Goodwill & Intangibles	n/a	n/a	n/a	-5.09M	n/a	n/a
Total Long-Term Assets	10.84M	12.8M	14.67M	15.54M	15.73M	11.62M
Total Assets	71.08M	60.93M	139.16M	218.06M	36.32M	62.72M
Account Payables	2.57M	1.05M	3.13M	3.14M	5.44M	2.52M
Deferred Revenue	13.52M	n/a	n/a	8.75M	13.73M	n/a
Short-Term Debt	1.19M	3.31M	6.67M	n/a	2.33M	n/a
Other Current Liabilities	9.98M	6.9M	82K	82K	82K	n/a
Total Current Liabilities	27.26M	15.96M	21.12M	12.78M	22.16M	5.21M
Long-Term Debt	n/a	n/a	3.17M	9.63M	7.41M	9.61M
Other Long-Term Liabilities	n/a	1.00	45K	118K	79.13M	68.41M
Total Long-Term Liabilities	26.22M	8.14M	12.4M	19.85M	97.45M	87.04M
Total Liabilities	53.48M	24.1M	33.52M	32.63M	119.6M	92.25M
Total Debt	8.14M	11.46M	19.94M	20.54M	21.22M	18.63M
Common Stock	5K	3K	3K	3K	1K	n/a
Retained Earnings	-383.75M	-325.51M	-249.11M	-160.89M	-85.09M	-29.87M
Comprehensive Income	n/a	n/a	n/a	-218.06M	-78M	n/a
Shareholders Equity	17.6M	36.83M	105.65M	185.43M	-83.29M	-29.52M
Total Investments	n/a	1.59M	1.56M	1.55M	1.55M	194K